Compare SEM & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEM | PRCT |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2009 | 2021 |
| Metric | SEM | PRCT |
|---|---|---|
| Price | $15.29 | $36.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $16.33 | ★ $51.50 |
| AVG Volume (30 Days) | 1.2M | ★ 1.6M |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.87 | N/A |
| Revenue | ★ $5,368,760,000.00 | $299,907,000.00 |
| Revenue This Year | $5.53 | $48.34 |
| Revenue Next Year | $4.33 | $29.35 |
| P/E Ratio | $20.32 | ★ N/A |
| Revenue Growth | 45.29 | ★ 50.07 |
| 52 Week Low | $11.65 | $27.80 |
| 52 Week High | $20.83 | $92.92 |
| Indicator | SEM | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 65.42 | 62.12 |
| Support Level | $14.76 | $33.27 |
| Resistance Level | $15.55 | $38.11 |
| Average True Range (ATR) | 0.44 | 1.83 |
| MACD | 0.04 | 0.72 |
| Stochastic Oscillator | 50.41 | 80.10 |
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.